Tislelizumab Interactions
There are 593 drugs known to interact with tislelizumab, along with 5 disease interactions. Of the total drug interactions, 3 are major, and 590 are moderate.
- View all 593 medications that may interact with tislelizumab
- View tislelizumab disease interactions (5)
Most frequently checked interactions
View interaction reports for tislelizumab and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Bylvay (odevixibat)
- Cabenuva (cabotegravir / rilpivirine)
- Cablivi (caplacizumab)
- Calquence (acalabrutinib)
- Camzyos (mavacamten)
- Caplyta (lumateperone)
- Caprelsa (vandetanib)
Tislelizumab disease interactions
There are 5 disease interactions with tislelizumab which include:
Report options
More about tislelizumab
- tislelizumab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Taxotere
Taxotere (docetaxel) treats breast cancer, lung cancer, prostate cancer and stomach cancer. Learn ...
Lonsurf
Lonsurf is an oral combination tablet that contains tipiracil and trifluridine which may be used to ...
Trazimera
Trazimera (trastuzumab-qyyp) is a biosimilar to Herceptin that may be used to treat certain types ...
Docetaxel
Docetaxel is used for breast cancer, breast cancer, metastatic, gastric cancer, head and neck ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.